Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Pharmaceutical ManufacturingEstablished Manufacturers
Research, Drug Development & Manufacturing

Catalent

Global CDMO supporting pharmaceutical development and manufacturing, including explicit psychedelic-related cGMP drug-product programs in sponsor disclosures.

Manufacturing Snapshot

Established CDMO / Manufacturer

Scope & Capabilities

Drug Product ManufacturingFormulation DevelopmentRegulatory / CMC SupportCDMO Services

Supply Use Cases

Clinical TrialsCommercial / Licensed SupplyPartner-Only Supply

GxP / Compliance

cGMPGeneral GxP

Facilities & Access

Global network with specialized oral dose and clinical/commercial manufacturing sites used by psychedelic-program sponsors.

Manufacturing Details

Supported Substances

Incannex disclosed Catalent engagement for cGMP psilocybin drug-product development and manufacturing for PsiGAD/PSX-001. MindMed disclosed Catalent licensing for MM-120 ODT formulation technology.

Manufacturing Sources

Incannex Engages Catalent for cGMP Psilocybin Drug Product

https://www.globenewswire.com/news-release/2023/03/03/2620152/0/en/Incannex-Engages-Catalent-for-Development-and-cGMP-Manufacture-of-Psilocybin-Drug-Product-for-Clinical-Trials-and-Potential-Commercial-Use.html

MindMed License Agreement with Catalent for MM-120 ODT

https://mindmed.co/news/press-release/mindmed-announces-exclusive-license-agreement-with-catalent-for-its-patented-zydis-fast-dissolve-technology-for-use-with-mm-120/

Quick Facts

Website
Visit